These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24597517)

  • 41. bcROCsurface: an R package for correcting verification bias in estimation of the ROC surface and its volume for continuous diagnostic tests.
    To Duc K
    BMC Bioinformatics; 2017 Nov; 18(1):503. PubMed ID: 29151019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimation of disease prevalence, true positive rate, and false positive rate of two screening tests when disease verification is applied on only screen-positives: a hierarchical model using multi-center data.
    Stock EM; Stamey JD; Sankaranarayanan R; Young DM; Muwonge R; Arbyn M
    Cancer Epidemiol; 2012 Apr; 36(2):153-60. PubMed ID: 21856264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect.
    Walter SD; Macaskill P; Lord SJ; Irwig L
    Stat Med; 2012 May; 31(11-12):1129-38. PubMed ID: 22351623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Forcing dichotomous disease classification from reference standards leads to bias in diagnostic accuracy estimates: A simulation study.
    Jenniskens K; Naaktgeboren CA; Reitsma JB; Hooft L; Moons KGM; van Smeden M
    J Clin Epidemiol; 2019 Jul; 111():1-10. PubMed ID: 30904568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A non-inferiority test for diagnostic accuracy based on the paired partial areas under ROC curves.
    Li CR; Liao CT; Liu JP
    Stat Med; 2008 May; 27(10):1762-76. PubMed ID: 17968858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing diagnostic tests once an optimal cutoff point has been selected.
    Linnet K; Brandt E
    Clin Chem; 1986 Jul; 32(7):1341-6. PubMed ID: 3719943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
    Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
    Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling rater diagnostic skills in binary classification processes.
    Lin X; Chen H; Edwards D; Nelson KP
    Stat Med; 2018 Feb; 37(4):557-571. PubMed ID: 29094378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statistical analysis of textural features for improved classification of oral histopathological images.
    Muthu Rama Krishnan M; Shah P; Chakraborty C; Ray AK
    J Med Syst; 2012 Apr; 36(2):865-81. PubMed ID: 20703647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices.
    Obuchowski NA; McClish DK
    Stat Med; 1997 Jul; 16(13):1529-42. PubMed ID: 9249923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating diagnostic accuracy in the face of multiple reference standards.
    Naaktgeboren CA; de Groot JA; van Smeden M; Moons KG; Reitsma JB
    Ann Intern Med; 2013 Aug; 159(3):195-202. PubMed ID: 23922065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
    Meklin J; SyrjÄnen K; Eskelinen M
    Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thoracic imaging tests for the diagnosis of COVID-19.
    Salameh JP; Leeflang MM; Hooft L; Islam N; McGrath TA; van der Pol CB; Frank RA; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Damen JA; Wang J; ; McInnes MD
    Cochrane Database Syst Rev; 2020 Sep; 9():CD013639. PubMed ID: 32997361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Point-of-care oral cytology tool for the screening and assessment of potentially malignant oral lesions.
    McRae MP; Modak SS; Simmons GW; Trochesset DA; Kerr AR; Thornhill MH; Redding SW; Vigneswaran N; Kang SK; Christodoulides NJ; Murdoch C; Dietl SJ; Markham R; McDevitt JT
    Cancer Cytopathol; 2020 Mar; 128(3):207-220. PubMed ID: 32032477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of an accuracy index of a diagnostic biomarker when the reference biomarker is continuous and measured with error.
    Wu M; Zhang D; Liu A
    J Biopharm Stat; 2016; 26(6):1111-1117. PubMed ID: 27548574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of dependent errors in the assessment of diagnostic test performance.
    Torrance-Rynard VL; Walter SD
    Stat Med; 1997 Oct; 16(19):2157-75. PubMed ID: 9330426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accounting for nonignorable verification bias in assessment of diagnostic tests.
    Kosinski AS; Barnhart HX
    Biometrics; 2003 Mar; 59(1):163-71. PubMed ID: 12762453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Semiparametric estimation of the covariate-specific ROC curve in presence of ignorable verification bias.
    Liu D; Zhou XH
    Biometrics; 2011 Sep; 67(3):906-16. PubMed ID: 21361890
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.